Skip to content

The effect of melatonin supplementation on obesity management

The effects of melatonin supplementation on nutritional status, oxidative stress, metabolic and inflammatory parameters in obese women undergoing weight loss diet

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012122411867N1
Enrollment
46
Registered
2013-07-01
Start date
2013-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: melatonin which is a natural hormone in the body and regulates sleep will be administered as oral supplement at a dose of 6 milligram (2 melatonin tablet, 3 mg ea
made by Nature Made, USA) 2 hours before bed time for 40 days with weight loss diet. Intervention 2: Control group will receive 6 mg placebo ( 2 tablet, 3 mg each containing cellulose, silicon dioxi
Treatment - Drugs
Placebo
Intervention group: melatonin which is a natural hormone in the body and regulates sleep will be administered as oral supplement at a dose of 6 milligram (2 melatonin tablet, 3 mg each
made by Nature Made, USA) 2 hours before bed time for 40 days with weight loss diet.
Control group will receive 6 mg placebo ( 2 tablet, 3 mg each containing cellulose, silicon dioxide and starch) 2 hours before bed time for 40 days with weight loss diet.

Sponsors

Vice-Chancellor for Research, Tabriz University of Medical Sciences- Nutrition Research Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Volunteer women with body mass index(BMI) =30 or more, aged between 20-50 years with maintained weight during the last six months Exclusion criteria: Include pregnancy and lactation, menopause, smoking, alcohol consumption, having endocrine or kidney disease, depression, taking tranquilizers, contraceptives, anti- inflammatory, glucose and lipid- lowering drugs. Also taking any kind of antioxidant supplements in the last 3 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Adiponectin. Timepoint: The onset and end of the study. Method of measurement: ELISA.;Glucose. Timepoint: The onset and end of the study. Method of measurement: Enzymatic colorimetric.;Insulin. Timepoint: The onset and end of the study. Method of measurement: Chemiluminescence.;High sensitive c- reactive protein. Timepoint: the onset and end of the study. Method of measurement: immunoturbidometry.;Leptin. Timepoint: The onset and end of the study. Method of measurement: ELISA.;Nutritional status. Timepoint: The onset and end of the study. Method of measurement: Measurement of energy and nutrients intake using 24-hour dietary recall method and anthropometric measurement using scale and stadiometer.;Total antioxidant capacity. Timepoint: The onset and end of the study. Method of measurement: Spectrophotometry.;LDL-C. Timepoint: The onset and end of the study. Method of measurement: Enzymatic colorimetric.;Total cholesterol. Timepoint: The onset and end of the study. Method of measurement: Enzymatic colorimetric.;Malondialdehyde. Timepoint: The onset and end of the study. Method of measurement: Spectrophotometry.;HDL-C. Timepoint: The onset and end of the study. Method of measurement: Enzymatic colorimetric.;Triglyceride. Timepoint: The onset and end of the study. Method of measurement: Enzymatic colorimetric.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Alireza Ostadrahimi

Faculty of Health and Nutrition, Tabriz University Of Medical Sciences

nut-rc@tbzmed.ac.ir+98 41 1335 2295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026